Transitioning children with complex health needs such as those with SCN2A or other developmental epileptic encephalopathies is challenging. 

Dr Danielle Andrade from University of Toronto has been instrumental in producing a number of transition guides and her ongoing research hopes to help further improve the process of transition. People aged 18 years or older can participate in this research by contacting Marlene Rong via marlene.rong@uhnresearch.ca

You can listen to and subscribe to the SCN2A Insights podcast via Apple Podcasts,  Spotify, and Google Podcasts or in your podcast app. This podcast series is supported by an educational grant from Praxis Precision Medicines.

Links: 
Dr Andrade bio
Dravet syndrome (SCN1A) transition guide
Video on transition research for people aged 18+
To participate in current research contact Marlene Rong via marlene.rong@uhnresearch.ca

Transitioning children with complex health needs such as those with SCN2A or other developmental epileptic encephalopathies is challenging.&nbsp;
Dr Danielle Andrade from University of Toronto has been instrumental in producing a number of transition guides and her ongoing research hopes to help further improve the process of transition. People aged 18 years or older can participate in this research by contacting Marlene Rong via <a href="mailto:marlene.rong@uhnresearch.ca">marlene.rong@uhnresearch.ca</a>
You can listen to and subscribe to the SCN2A Insights podcast via&nbsp;<a href="https://podcasts.apple.com/au/podcast/scn2a-insights/id1479681243?mt=2&amp;app=podcast">Apple Podcasts</a>, &nbsp;<a href="https://open.spotify.com/show/6KrDEmN7XPh8oDR7zR48cy">Spotify</a>, and&nbsp;<a href="https://podcasts.google.com/?feed=aHR0cHM6Ly93d3cub21ueWNvbnRlbnQuY29tL2QvcGxheWxpc3QvMjNkMTM3YTEtNDQxNi00MGQ2LWE1ZmMtYTUyOTAwMDFlY2RkLzA5MmMwZGNhLWQ0OTgtNDlkYy1hY2RkLWFhNzgwMGI3YWIyZC9jZDc2ZmU4Ni05MTA3LTQxMzYtYmY4Mi1hYTc4MDBiODVmZWQvcG9kY2FzdC5yc3M%3D">Google Podcasts</a>&nbsp;or in your podcast app. This podcast series is supported by an educational grant from <a href="https://praxismedicines.com/">Praxis Precision Medicines</a>.
Links:&nbsp;
<ul>
<li><a href="https://www.uhnresearch.ca/researcher/danielle-andrade">Dr Andrade bio</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/34624600">Dravet syndrome (SCN1A) transition guide</a></li>
<li><a href="https://www.youtube.com/watch?v=WyhRDePe0Jc">Video on transition research for people aged 18+</a></li>
<li>To participate in current research contact Marlene Rong via <a href="mailto:marlene.rong@uhnresearch.ca">marlene.rong@uhnresearch.ca</a></li>
</ul>

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders. Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders. Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

SCN2A Insights brings you the latest research and clinical information on SCN2A from experts around the world.

SCN2A Insights

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders.

Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

Listen to SCN2A Insights to keep up to date with the latest research in SCN2A, genetic epilepsy and rare genetic disorders.
Hosted by Ms Kris Pierce, RARE Global Advocacy Leadership Council member, and Dr David Cunnington, parents of Will, who has SCN2A.

Transitioning children with complex health needs such as those with SCN2A or other developmental epileptic encephalopathies is challenging.   Dr Danielle Andrade from University of Toronto has been instrumental in producing a number of guides to the transition process and her ongoing research hopes to help further improve the process of transition.

Advertisement